Search results
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
TipRanks via Yahoo Finance· 2 months agoCRISPR Therapeutics (NASDAQ:CRSP) stock has been slowly heading lower in recent months, and I don’t...
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health
Motley Fool· 1 year agoCRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to...
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
Motley Fool via Yahoo Finance· 6 months agoIt's now a new ballgame for CRISPR Therapeutics (NASDAQ: CRSP). The company, along with its big...
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?
Motley Fool via Yahoo Finance· 5 months agoCRISPR Therapeutics (NASDAQ: CRSP) has put itself on the map of the healthcare industry as a serious...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 6 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
Investor's Business Daily· 2 years agoCrispr Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Friday,...
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
Motley Fool via Yahoo Finance· 4 months agoWith CRISPR Therapeutics (NASDAQ: CRSP) in the news thanks to its successful work in developing...
Is CRISPR Therapeutics a Buy in the New Bull Market?
Motley Fool via Yahoo Finance· 4 months agoCRISPR Therapeutics (NASDAQ: CRSP) soared 54% last year as growth stocks rallied and the company itself moved toward an important milestone: the approval...
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its...
Motley Fool via Yahoo Finance· 6 months agoDecember has been a big month for CRISPR Therapeutics (NASDAQ: CRSP). On Dec. 8, the Food and Drug...